Table of Content

1 Anti-Obesity Drugs (Anti-obesity Medication) Market Overview
1.1 Anti-Obesity Drugs (Anti-obesity Medication) Product Scope
1.2 Anti-Obesity Drugs (Anti-obesity Medication) Segment by Type
1.2.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type (2016 & 2021 & 2027)
1.2.2 Prescription Drugs
1.2.3 OTC Drugs
1.3 Anti-Obesity Drugs (Anti-obesity Medication) Segment by Application
1.3.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Childhood (0-6)
1.3.3 Juvenile (7-17)
1.3.4 Youth (18-40)
1.3.5 Middle Aged (41-60)
1.3.6 Elderly (Above 60)
1.4 Anti-Obesity Drugs (Anti-obesity Medication) Market Estimates and Forecasts (2016-2027)
1.4.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Price Trends (2016-2027)

2 Anti-Obesity Drugs (Anti-obesity Medication) Estimates and Forecasts by Region
2.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Region (2016-2021)
2.2.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Region (2016-2021)
2.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Anti-Obesity Drugs (Anti-obesity Medication) Estimates and Projections (2016-2027)
2.4.2 Europe Anti-Obesity Drugs (Anti-obesity Medication) Estimates and Projections (2016-2027)
2.4.3 China Anti-Obesity Drugs (Anti-obesity Medication) Estimates and Projections (2016-2027)
2.4.4 Japan Anti-Obesity Drugs (Anti-obesity Medication) Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Anti-Obesity Drugs (Anti-obesity Medication) Estimates and Projections (2016-2027)
2.4.6 India Anti-Obesity Drugs (Anti-obesity Medication) Estimates and Projections (2016-2027)

3 Global Anti-Obesity Drugs (Anti-obesity Medication) Competition Landscape by Players
3.1 Global Top Anti-Obesity Drugs (Anti-obesity Medication) Players by Sales (2016-2021)
3.2 Global Top Anti-Obesity Drugs (Anti-obesity Medication) Players by Revenue (2016-2021)
3.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti-Obesity Drugs (Anti-obesity Medication) as of 2020)
3.4 Global Anti-Obesity Drugs (Anti-obesity Medication) Average Price by Company (2016-2021)
3.5 Manufacturers Anti-Obesity Drugs (Anti-obesity Medication) Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Type
4.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Historic Market Review by Type (2016-2021)
4.1.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Type (2016-2021)
4.1.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Type (2016-2021)
4.1.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Price by Type (2016-2021)
4.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Forecast by Type (2022-2027)
4.2.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Forecast by Type (2022-2027)
4.2.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Price Forecast by Type (2022-2027)

5 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Application
5.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Historic Market Review by Application (2016-2021)
5.1.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Application (2016-2021)
5.1.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Application (2016-2021)
5.1.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Price by Application (2016-2021)
5.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Forecast by Application (2022-2027)
5.2.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Forecast by Application (2022-2027)
5.2.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Price Forecast by Application (2022-2027)

6 North America Anti-Obesity Drugs (Anti-obesity Medication) Market Facts & Figures
6.1 North America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Company
6.1.1 North America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Company (2016-2021)
6.1.2 North America Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Company (2016-2021)
6.2 North America Anti-Obesity Drugs (Anti-obesity Medication) Sales Breakdown by Type
6.2.1 North America Anti-Obesity Drugs (Anti-obesity Medication) Sales Breakdown by Type (2016-2021)
6.2.2 North America Anti-Obesity Drugs (Anti-obesity Medication) Sales Breakdown by Type (2022-2027)
6.3 North America Anti-Obesity Drugs (Anti-obesity Medication) Sales Breakdown by Application
6.3.1 North America Anti-Obesity Drugs (Anti-obesity Medication) Sales Breakdown by Application (2016-2021)
6.3.2 North America Anti-Obesity Drugs (Anti-obesity Medication) Sales Breakdown by Application (2022-2027)

7 Europe Anti-Obesity Drugs (Anti-obesity Medication) Market Facts & Figures
7.1 Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales by Company
7.1.1 Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales by Company (2016-2021)
7.1.2 Europe Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Company (2016-2021)
7.2 Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales Breakdown by Type
7.2.1 Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales Breakdown by Type (2016-2021)
7.2.2 Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales Breakdown by Type (2022-2027)
7.3 Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales Breakdown by Application
7.3.1 Europe 150 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 150 Sales Breakdown by Application (2022-2027)

8 China Anti-Obesity Drugs (Anti-obesity Medication) Market Facts & Figures
8.1 China Anti-Obesity Drugs (Anti-obesity Medication) Sales by Company
8.1.1 China Anti-Obesity Drugs (Anti-obesity Medication) Sales by Company (2016-2021)
8.1.2 China Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Company (2016-2021)
8.2 China Anti-Obesity Drugs (Anti-obesity Medication) Sales Breakdown by Type
8.2.1 China Anti-Obesity Drugs (Anti-obesity Medication) Sales Breakdown by Type (2016-2021)
8.2.2 China Anti-Obesity Drugs (Anti-obesity Medication) Sales Breakdown by Type (2022-2027)
8.3 China Anti-Obesity Drugs (Anti-obesity Medication) Sales Breakdown by Application
8.3.1 China 175 Sales Breakdown by Application (2016-2021)
8.3.2 China 175 Sales Breakdown by Application (2022-2027)

9 Japan Anti-Obesity Drugs (Anti-obesity Medication) Market Facts & Figures
9.1 Japan Anti-Obesity Drugs (Anti-obesity Medication) Sales by Company
9.1.1 Japan Anti-Obesity Drugs (Anti-obesity Medication) Sales by Company (2016-2021)
9.1.2 Japan Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Company (2016-2021)
9.2 Japan Anti-Obesity Drugs (Anti-obesity Medication) Sales Breakdown by Type
9.2.1 Japan Anti-Obesity Drugs (Anti-obesity Medication) Sales Breakdown by Type (2016-2021)
9.2.2 Japan Anti-Obesity Drugs (Anti-obesity Medication) Sales Breakdown by Type (2022-2027)
9.3 Japan Anti-Obesity Drugs (Anti-obesity Medication) Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Anti-Obesity Drugs (Anti-obesity Medication) Market Facts & Figures
10.1 Southeast Asia Anti-Obesity Drugs (Anti-obesity Medication) Sales by Company
10.1.1 Southeast Asia Anti-Obesity Drugs (Anti-obesity Medication) Sales by Company (2016-2021)
10.1.2 Southeast Asia Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Company (2016-2021)
10.2 Southeast Asia Anti-Obesity Drugs (Anti-obesity Medication) Sales Breakdown by Type
10.2.1 Southeast Asia Anti-Obesity Drugs (Anti-obesity Medication) Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Anti-Obesity Drugs (Anti-obesity Medication) Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Anti-Obesity Drugs (Anti-obesity Medication) Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Anti-Obesity Drugs (Anti-obesity Medication) Market Facts & Figures
11.1 India Anti-Obesity Drugs (Anti-obesity Medication) Sales by Company
11.1.1 India Anti-Obesity Drugs (Anti-obesity Medication) Sales by Company (2016-2021)
11.1.2 India Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Company (2016-2021)
11.2 India Anti-Obesity Drugs (Anti-obesity Medication) Sales Breakdown by Type
11.2.1 India Anti-Obesity Drugs (Anti-obesity Medication) Sales Breakdown by Type (2016-2021)
11.2.2 India Anti-Obesity Drugs (Anti-obesity Medication) Sales Breakdown by Type (2022-2027)
11.3 India Anti-Obesity Drugs (Anti-obesity Medication) Sales Breakdown by Application
11.3.1 India Anti-Obesity Drugs (Anti-obesity Medication) Sales Breakdown by Application (2016-2021)
11.3.2 India Anti-Obesity Drugs (Anti-obesity Medication) Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Anti-Obesity Drugs (Anti-obesity Medication) Business
12.1 Zafgan
12.1.1 Zafgan Corporation Information
12.1.2 Zafgan Business Overview
12.1.3 Zafgan Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Zafgan Anti-Obesity Drugs (Anti-obesity Medication) Products Offered
12.1.5 Zafgan Recent Development
12.2 Vivus
12.2.1 Vivus Corporation Information
12.2.2 Vivus Business Overview
12.2.3 Vivus Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Vivus Anti-Obesity Drugs (Anti-obesity Medication) Products Offered
12.2.5 Vivus Recent Development
12.3 Shionogi
12.3.1 Shionogi Corporation Information
12.3.2 Shionogi Business Overview
12.3.3 Shionogi Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Shionogi Anti-Obesity Drugs (Anti-obesity Medication) Products Offered
12.3.5 Shionogi Recent Development
12.4 Sanofi
12.4.1 Sanofi Corporation Information
12.4.2 Sanofi Business Overview
12.4.3 Sanofi Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Sanofi Anti-Obesity Drugs (Anti-obesity Medication) Products Offered
12.4.5 Sanofi Recent Development
12.5 Rhythm Pharmaceuticals
12.5.1 Rhythm Pharmaceuticals Corporation Information
12.5.2 Rhythm Pharmaceuticals Business Overview
12.5.3 Rhythm Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Rhythm Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Products Offered
12.5.5 Rhythm Pharmaceuticals Recent Development
12.6 Pfizer
12.6.1 Pfizer Corporation Information
12.6.2 Pfizer Business Overview
12.6.3 Pfizer Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Pfizer Anti-Obesity Drugs (Anti-obesity Medication) Products Offered
12.6.5 Pfizer Recent Development
12.7 Orexigen Therapeutics
12.7.1 Orexigen Therapeutics Corporation Information
12.7.2 Orexigen Therapeutics Business Overview
12.7.3 Orexigen Therapeutics Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Orexigen Therapeutics Anti-Obesity Drugs (Anti-obesity Medication) Products Offered
12.7.5 Orexigen Therapeutics Recent Development
12.8 Novo Nordisk
12.8.1 Novo Nordisk Corporation Information
12.8.2 Novo Nordisk Business Overview
12.8.3 Novo Nordisk Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Novo Nordisk Anti-Obesity Drugs (Anti-obesity Medication) Products Offered
12.8.5 Novo Nordisk Recent Development
12.9 Norgine
12.9.1 Norgine Corporation Information
12.9.2 Norgine Business Overview
12.9.3 Norgine Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Norgine Anti-Obesity Drugs (Anti-obesity Medication) Products Offered
12.9.5 Norgine Recent Development
12.10 Nalpropion Pharmaceuticals Inc.
12.10.1 Nalpropion Pharmaceuticals Inc. Corporation Information
12.10.2 Nalpropion Pharmaceuticals Inc. Business Overview
12.10.3 Nalpropion Pharmaceuticals Inc. Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Nalpropion Pharmaceuticals Inc. Anti-Obesity Drugs (Anti-obesity Medication) Products Offered
12.10.5 Nalpropion Pharmaceuticals Inc. Recent Development
12.11 Merck
12.11.1 Merck Corporation Information
12.11.2 Merck Business Overview
12.11.3 Merck Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Merck Anti-Obesity Drugs (Anti-obesity Medication) Products Offered
12.11.5 Merck Recent Development
12.12 GlaxoSmithKline
12.12.1 GlaxoSmithKline Corporation Information
12.12.2 GlaxoSmithKline Business Overview
12.12.3 GlaxoSmithKline Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue and Gross Margin (2016-2021)
12.12.4 GlaxoSmithKline Anti-Obesity Drugs (Anti-obesity Medication) Products Offered
12.12.5 GlaxoSmithKline Recent Development
12.13 F.Hoffmann-La Roche
12.13.1 F.Hoffmann-La Roche Corporation Information
12.13.2 F.Hoffmann-La Roche Business Overview
12.13.3 F.Hoffmann-La Roche Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue and Gross Margin (2016-2021)
12.13.4 F.Hoffmann-La Roche Anti-Obesity Drugs (Anti-obesity Medication) Products Offered
12.13.5 F.Hoffmann-La Roche Recent Development
12.14 Eisai
12.14.1 Eisai Corporation Information
12.14.2 Eisai Business Overview
12.14.3 Eisai Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Eisai Anti-Obesity Drugs (Anti-obesity Medication) Products Offered
12.14.5 Eisai Recent Development
12.15 Boehringer Ingelheim
12.15.1 Boehringer Ingelheim Corporation Information
12.15.2 Boehringer Ingelheim Business Overview
12.15.3 Boehringer Ingelheim Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Boehringer Ingelheim Anti-Obesity Drugs (Anti-obesity Medication) Products Offered
12.15.5 Boehringer Ingelheim Recent Development
12.16 Bayer AG
12.16.1 Bayer AG Corporation Information
12.16.2 Bayer AG Business Overview
12.16.3 Bayer AG Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Bayer AG Anti-Obesity Drugs (Anti-obesity Medication) Products Offered
12.16.5 Bayer AG Recent Development
12.17 AstraZeneca
12.17.1 AstraZeneca Corporation Information
12.17.2 AstraZeneca Business Overview
12.17.3 AstraZeneca Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue and Gross Margin (2016-2021)
12.17.4 AstraZeneca Anti-Obesity Drugs (Anti-obesity Medication) Products Offered
12.17.5 AstraZeneca Recent Development
12.18 Arena Pharmaceuticals
12.18.1 Arena Pharmaceuticals Corporation Information
12.18.2 Arena Pharmaceuticals Business Overview
12.18.3 Arena Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue and Gross Margin (2016-2021)
12.18.4 Arena Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Products Offered
12.18.5 Arena Pharmaceuticals Recent Development
12.19 Amylin
12.19.1 Amylin Corporation Information
12.19.2 Amylin Business Overview
12.19.3 Amylin Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue and Gross Margin (2016-2021)
12.19.4 Amylin Anti-Obesity Drugs (Anti-obesity Medication) Products Offered
12.19.5 Amylin Recent Development
12.20 Alizyme
12.20.1 Alizyme Corporation Information
12.20.2 Alizyme Business Overview
12.20.3 Alizyme Anti-Obesity Drugs (Anti-obesity Medication) Sales, Revenue and Gross Margin (2016-2021)
12.20.4 Alizyme Anti-Obesity Drugs (Anti-obesity Medication) Products Offered
12.20.5 Alizyme Recent Development

13 Anti-Obesity Drugs (Anti-obesity Medication) Manufacturing Cost Analysis
13.1 Anti-Obesity Drugs (Anti-obesity Medication) Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Anti-Obesity Drugs (Anti-obesity Medication)
13.4 Anti-Obesity Drugs (Anti-obesity Medication) Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Anti-Obesity Drugs (Anti-obesity Medication) Distributors List
14.3 Anti-Obesity Drugs (Anti-obesity Medication) Customers

15 Market Dynamics
15.1 Anti-Obesity Drugs (Anti-obesity Medication) Market Trends
15.2 Anti-Obesity Drugs (Anti-obesity Medication) Drivers
15.3 Anti-Obesity Drugs (Anti-obesity Medication) Market Challenges
15.4 Anti-Obesity Drugs (Anti-obesity Medication) Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units) by Region (2016-2021)
Table 5. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Region (2016-2021)
Table 6. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Share by Region (2016-2021)
Table 8. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Share Forecast by Region (2022-2027)
Table 12. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Share by Company (2016-2021)
Table 14. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Share by Company (2016-2021)
Table 16. Global Anti-Obesity Drugs (Anti-obesity Medication) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Obesity Drugs (Anti-obesity Medication) as of 2020)
Table 17. Global Anti-Obesity Drugs (Anti-obesity Medication) Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Anti-Obesity Drugs (Anti-obesity Medication) Manufacturing Sites and Area Served
Table 19. Manufacturers Anti-Obesity Drugs (Anti-obesity Medication) Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units) by Type (2016-2021)
Table 22. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Share by Type (2016-2021)
Table 23. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Anti-Obesity Drugs (Anti-obesity Medication) Price (USD/Unit) by Type (2016-2021)
Table 25. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Share by Type (2022-2027)
Table 26. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Share by Type (2022-2027)
Table 28. Global Anti-Obesity Drugs (Anti-obesity Medication) Price (USD/Unit) by Type (2022-2027)
Table 29. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units) by Application (2016-2021)
Table 30. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Share by Application (2016-2021)
Table 31. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Anti-Obesity Drugs (Anti-obesity Medication) Price (USD/Unit) by Application (2016-2021)
Table 33. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units) by Application (2022-2027)
Table 34. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Share by Application (2022-2027)
Table 35. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Share by Application (2022-2027)
Table 37. Global Anti-Obesity Drugs (Anti-obesity Medication) Price (USD/Unit) by Application (2022-2027)
Table 38. North America Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units) by Company (2016-2021)
Table 39. North America Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Company (2016-2021)
Table 40. North America Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Company (2016-2021)
Table 42. North America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type (2016-2021) & (K Units)
Table 43. North America Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Type (2016-2021)
Table 44. North America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type (2022-2027) & (K Units)
Table 45. North America Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Type (2022-2027)
Table 46. North America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application (2016-2021) & (K Units)
Table 47. North America Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Application (2016-2021)
Table 48. North America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application (2022-2027) & (K Units)
Table 49. North America Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Application (2022-2027)
Table 50. Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units) by Company (2016-2021)
Table 51. Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Company (2016-2021)
Table 52. Europe Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Company (2016-2021)
Table 54. Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type (2016-2021) & (K Units)
Table 55. Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Type (2016-2021)
Table 56. Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type (2022-2027) & (K Units)
Table 57. Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Type (2022-2027)
Table 58. Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application (2016-2021) & (K Units)
Table 59. Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Application (2016-2021)
Table 60. Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application (2022-2027) & (K Units)
Table 61. Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Application (2022-2027)
Table 62. China Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units) by Company (2016-2021)
Table 63. China Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Company (2016-2021)
Table 64. China Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Company (2016-2021)
Table 66. China Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type (2016-2021) & (K Units)
Table 67. China Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Type (2016-2021)
Table 68. China Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type (2022-2027) & (K Units)
Table 69. China Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Type (2022-2027)
Table 70. China Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application (2016-2021) & (K Units)
Table 71. China Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Application (2016-2021)
Table 72. China Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application (2022-2027) & (K Units)
Table 73. China Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Application (2022-2027)
Table 74. Japan Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units) by Company (2016-2021)
Table 75. Japan Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Company (2016-2021)
Table 76. Japan Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Company (2016-2021)
Table 78. Japan Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type (2016-2021) & (K Units)
Table 79. Japan Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Type (2016-2021)
Table 80. Japan Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type (2022-2027) & (K Units)
Table 81. Japan Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Type (2022-2027)
Table 82. Japan Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application (2016-2021) & (K Units)
Table 83. Japan Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Application (2016-2021)
Table 84. Japan Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application (2022-2027) & (K Units)
Table 85. Japan Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Application (2022-2027)
Table 98. India Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units) by Company (2016-2021)
Table 99. India Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Company (2016-2021)
Table 100. India Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Company (2016-2021)
Table 102. India Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type (2016-2021) & (K Units)
Table 103. India Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Type (2016-2021)
Table 104. India Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type (2022-2027) & (K Units)
Table 105. India Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Type (2022-2027)
Table 106. India Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application (2016-2021) & (K Units)
Table 107. India Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Application (2016-2021)
Table 108. India Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application (2022-2027) & (K Units)
Table 109. India Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Application (2022-2027)
Table 110. Zafgan Corporation Information
Table 111. Zafgan Description and Business Overview
Table 112. Zafgan Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. Zafgan Anti-Obesity Drugs (Anti-obesity Medication) Product
Table 114. Zafgan Recent Development
Table 115. Vivus Corporation Information
Table 116. Vivus Description and Business Overview
Table 117. Vivus Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. Vivus Anti-Obesity Drugs (Anti-obesity Medication) Product
Table 119. Vivus Recent Development
Table 120. Shionogi Corporation Information
Table 121. Shionogi Description and Business Overview
Table 122. Shionogi Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. Shionogi Anti-Obesity Drugs (Anti-obesity Medication) Product
Table 124. Shionogi Recent Development
Table 125. Sanofi Corporation Information
Table 126. Sanofi Description and Business Overview
Table 127. Sanofi Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. Sanofi Anti-Obesity Drugs (Anti-obesity Medication) Product
Table 129. Sanofi Recent Development
Table 130. Rhythm Pharmaceuticals Corporation Information
Table 131. Rhythm Pharmaceuticals Description and Business Overview
Table 132. Rhythm Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. Rhythm Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Product
Table 134. Rhythm Pharmaceuticals Recent Development
Table 135. Pfizer Corporation Information
Table 136. Pfizer Description and Business Overview
Table 137. Pfizer Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. Pfizer Anti-Obesity Drugs (Anti-obesity Medication) Product
Table 139. Pfizer Recent Development
Table 140. Orexigen Therapeutics Corporation Information
Table 141. Orexigen Therapeutics Description and Business Overview
Table 142. Orexigen Therapeutics Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 143. Orexigen Therapeutics Anti-Obesity Drugs (Anti-obesity Medication) Product
Table 144. Orexigen Therapeutics Recent Development
Table 145. Novo Nordisk Corporation Information
Table 146. Novo Nordisk Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 147. Novo Nordisk Description and Business Overview
Table 148. Novo Nordisk Anti-Obesity Drugs (Anti-obesity Medication) Product
Table 149. Novo Nordisk Recent Development
Table 150. Norgine Corporation Information
Table 151. Norgine Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 152. Norgine Description and Business Overview
Table 153. Norgine Anti-Obesity Drugs (Anti-obesity Medication) Product
Table 154. Norgine Recent Development
Table 155. Nalpropion Pharmaceuticals Inc. Corporation Information
Table 156. Nalpropion Pharmaceuticals Inc. Description and Business Overview
Table 157. Nalpropion Pharmaceuticals Inc. Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 158. Nalpropion Pharmaceuticals Inc. Anti-Obesity Drugs (Anti-obesity Medication) Product
Table 159. Nalpropion Pharmaceuticals Inc. Recent Development
Table 160. Merck Corporation Information
Table 161. Merck Description and Business Overview
Table 162. Merck Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 163. Merck Anti-Obesity Drugs (Anti-obesity Medication) Product
Table 164. Merck Recent Development
Table 165. GlaxoSmithKline Corporation Information
Table 166. GlaxoSmithKline Description and Business Overview
Table 167. GlaxoSmithKline Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 168. GlaxoSmithKline Anti-Obesity Drugs (Anti-obesity Medication) Product
Table 169. GlaxoSmithKline Recent Development
Table 170. F.Hoffmann-La Roche Corporation Information
Table 171. F.Hoffmann-La Roche Description and Business Overview
Table 172. F.Hoffmann-La Roche Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 173. F.Hoffmann-La Roche Anti-Obesity Drugs (Anti-obesity Medication) Product
Table 174. F.Hoffmann-La Roche Recent Development
Table 175. Eisai Corporation Information
Table 176. Eisai Description and Business Overview
Table 177. Eisai Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 178. Eisai Anti-Obesity Drugs (Anti-obesity Medication) Product
Table 179. Eisai Recent Development
Table 180. Boehringer Ingelheim Corporation Information
Table 181. Boehringer Ingelheim Description and Business Overview
Table 182. Boehringer Ingelheim Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 183. Boehringer Ingelheim Anti-Obesity Drugs (Anti-obesity Medication) Product
Table 184. Boehringer Ingelheim Recent Development
Table 185. Bayer AG Corporation Information
Table 186. Bayer AG Description and Business Overview
Table 187. Bayer AG Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 188. Bayer AG Anti-Obesity Drugs (Anti-obesity Medication) Product
Table 189. Bayer AG Recent Development
Table 190. AstraZeneca Corporation Information
Table 191. AstraZeneca Description and Business Overview
Table 192. AstraZeneca Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 193. AstraZeneca Anti-Obesity Drugs (Anti-obesity Medication) Product
Table 194. AstraZeneca Recent Development
Table 195. Arena Pharmaceuticals Corporation Information
Table 196. Arena Pharmaceuticals Description and Business Overview
Table 197. Arena Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 198. Arena Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Product
Table 199. Arena Pharmaceuticals Recent Development
Table 200. Amylin Corporation Information
Table 201. Amylin Description and Business Overview
Table 202. Amylin Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 203. Amylin Anti-Obesity Drugs (Anti-obesity Medication) Product
Table 204. Amylin Recent Development
Table 205. Alizyme Corporation Information
Table 206. Alizyme Description and Business Overview
Table 207. Alizyme Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 208. Alizyme Anti-Obesity Drugs (Anti-obesity Medication) Product
Table 209. Alizyme Recent Development
Table 210. Production Base and Market Concentration Rate of Raw Material
Table 211. Key Suppliers of Raw Materials
Table 212. Anti-Obesity Drugs (Anti-obesity Medication) Distributors List
Table 213. Anti-Obesity Drugs (Anti-obesity Medication) Customers List
Table 214. Anti-Obesity Drugs (Anti-obesity Medication) Market Trends
Table 215. Anti-Obesity Drugs (Anti-obesity Medication) Market Drivers
Table 216. Anti-Obesity Drugs (Anti-obesity Medication) Market Challenges
Table 217. Anti-Obesity Drugs (Anti-obesity Medication) Market Restraints
Table 218. Research Programs/Design for This Report
Table 219. Key Data Information from Secondary Sources
Table 220. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti-Obesity Drugs (Anti-obesity Medication) Product Picture
Figure 2. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Type in 2021 & 2027
Figure 3. Prescription Drugs Product Picture
Figure 4. OTC Drugs Product Picture
Figure 5. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Application in 2021 & 2027
Figure 6. Childhood (0-6) Examples
Figure 7. Juvenile (7-17) Examples
Figure 8. Youth (18-40) Examples
Figure 9. Middle Aged (41-60) Examples
Figure 10. Elderly (Above 60) Examples
Figure 11. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Growth Rate (2016-2027) & (US$ Million)
Figure 13. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units) Growth Rate (2016-2027)
Figure 14. Global Anti-Obesity Drugs (Anti-obesity Medication) Price Trends Growth Rate (2016-2027) (USD/Unit)
Figure 15. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Region: 2016 VS 2021
Figure 16. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Region: 2021 VS 2027
Figure 17. North America Anti-Obesity Drugs (Anti-obesity Medication) Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. North America Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units) Growth Rate (2016-2027)
Figure 19. Europe Anti-Obesity Drugs (Anti-obesity Medication) Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales (Million USD) Growth Rate (2016-2027)
Figure 21. China Anti-Obesity Drugs (Anti-obesity Medication) Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. China Anti-Obesity Drugs (Anti-obesity Medication) Sales (Million USD) and Growth Rate (2016-2027)
Figure 23. Japan Anti-Obesity Drugs (Anti-obesity Medication) Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Japan Anti-Obesity Drugs (Anti-obesity Medication) Sales (Million USD) Growth Rate (2016-2027)
Figure 25. Southeast Asia Anti-Obesity Drugs (Anti-obesity Medication) Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. Southeast Asia Anti-Obesity Drugs (Anti-obesity Medication) Sales (Million USD) Growth Rate (2016-2027)
Figure 27. India Anti-Obesity Drugs (Anti-obesity Medication) Revenue (Million USD) Growth Rate (2016-2027)
Figure 28. India Anti-Obesity Drugs (Anti-obesity Medication) Sales (Million USD) Growth Rate (2016-2027)
Figure 29. Global 5 Largest Anti-Obesity Drugs (Anti-obesity Medication) Players Market Share by Revenue in Anti-Obesity Drugs (Anti-obesity Medication): 2016 & 2020
Figure 30. Anti-Obesity Drugs (Anti-obesity Medication) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 31. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Share by Type (2016-2021)
Figure 32. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Growth Rate by Type in 2016 & 2020
Figure 33. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Share by Application (2016-2021)
Figure 34. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Growth Rate by Application in 2016 & 2020
Figure 35. North America Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Type in 2020
Figure 36. North America Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Application in 2020
Figure 37. Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Type in 2020
Figure 38. Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Application in 2020
Figure 39. China Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Type in 2020
Figure 40. China Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Application in 2020
Figure 41. Japan Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Type in 2020
Figure 42. Japan Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Application in 2020
Figure 43. Southeast Asia Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Type in 2020
Figure 44. Southeast Asia Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Application in 2020
Figure 45. India Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Type in 2020
Figure 46. India Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Application in 2020
Figure 47. Key Raw Materials Price Trend
Figure 48. Manufacturing Cost Structure of Anti-Obesity Drugs (Anti-obesity Medication)
Figure 49. Manufacturing Process Analysis of Anti-Obesity Drugs (Anti-obesity Medication)
Figure 50. Anti-Obesity Drugs (Anti-obesity Medication) Industrial Chain Analysis
Figure 51. Channels of Distribution
Figure 52. Distributors Profiles
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed